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Abstract
Background: Both manual therapy techniques and dry needling have shown to be effective treatment options for
the treatment of plantar heel pain; however, in recent years, other techniques based on dry needling (DN), such as
percutaneous needle electrolysis (PNE), have also emerged. Currently, PNE is being used in clinical practice to
manage myofascial trigger points, despite the lack of studies comparing the effects of this technique over dry
needling. Therefore, the aim of this randomized controlled study is to compare the effectiveness of DN versus
PNE for improving the level of pain experienced by patients suffering from plantar heel pain provoked by myofascial
trigger points.
Methods: A randomized controlled trial will be conducted with blinded participants and outcome assessors. A sample
of 94 patients with a medical diagnosis of plantar heel pain will be recruited and divided into two treatment groups.
Eligible participants will be randomly allocated to either (a) treatment group with DN and a self-stretching
home program or (b) treatment group with PNE and a self-stretching home program. Each group will receive
one treatment session per week over a period of 4 weeks. The primary outcome measure will be the pain
subscale of the Foot Health Status Questionnaire. The secondary outcome measures will be a visual analogue
scale for pain (average and highest level of pain experienced during the previous 48 h; level of pain immediately after
the treatment session) and health-related quality of life (assessed using the EuroQoL-5 dimensions). Cost-effectiveness
data will be extracted based on the EuroQoL-5 dimensions. Follow-up measurements will take place at baseline and at
4, 8, 12, 26, and 52 weeks.
Discussion: The justification for this trial is the need to improve current understanding regarding the effectiveness of
treatments targeting the rehabilitation of plantar heel pain. This study will be the first randomized controlled trial to
directly compare the effectiveness of DN and PNE combined with a specific stretching program for the treatment of
plantar heel pain provoked by myofascial trigger points.
Trial registration: Clinical Trials NCT03236779. Registered at clinicaltrials.gov 2 August 2017.
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Background
Plantar heel pain (PHP) is one of the main sources of
pain in the foot, causing soreness or tenderness in the
sole of the foot, under the heel, and which sometimes
extends into the medial arch [1, 2]. This condition af-
fects both athletic and sedentary individuals and does
not seem to be influenced by gender [2]. The incidence
and prevalence of plantar heel pain is uncertain; how-
ever, it is estimated that over the course of a lifetime,
10% of the population may suffer this condition [3, 4].
Furthermore, results from a high-quality epidemiological
study in the USA from the 1990s found that approxi-
mately one million patient visits to physicians per year
were due to PHP [5], with an associated annual cost of
around $300 million [6].
Plantar heel pain may include different sources of pain,
involving various diagnoses, such as myofascial pain syn-
drome, plantar fasciitis, or heel spur, among others [7].
The diagnosis is usually made based on the patient’s his-
tory and physical examination, including pain during the
first steps in the morning or after prolonged rest, as well
as pain during prolonged standing or walking [3, 4, 6];
more in-depth examinations are used only to rule out
other disorders causing inferior heel pain, such as tu-
mors, infections, and neuropathic pain (including tarsal
tunnel syndrome) [8, 9]. The proper identification of
the main cause of pain can be difficult as, usually,
this may be multifactorial [10]. Current heel pain
guidelines identify risk factors that include limited
ankle dorsiflexion ROM, high body mass index (BMI)
in nonathletic individuals, running, and work-related
weight-bearing activities [3, 4].
There is a lack of consensus regarding the ideal manage-
ment approach for PHP [11–13]. Clinical practice guide-
lines support the use of conservative treatment, such as
joint and soft tissue mobilization or self-stretching home
programs (SSHP) [3, 4]. In particular, SSHP has shown to
be effective for addressing PHP [3, 10, 14], while recent
randomized clinical trials (RCTs) have shown that there is
an additional effect reducing the severity of pain when
SSHP is combined with ischemic compression [15] and
with dry needling (DN) [16].
Despite its prevalence, the etiology of PHP is not
well understood [3, 4]. Although PHP may be pro-
voked by a tendinous injury affecting the plantar
fascia, it is well known that the presence of myofas-
cial trigger points (MTrPs) within the plantar and
lower leg musculature may play an important role in
people with PHP [17], and recent studies have based
their hypothesis on this assumption [15, 16, 18, 19].
Some of these have demonstrated the effectiveness of
manual therapy techniques (i.e., ischemic compres-
sion) [15, 19] while others have also demonstrated
the effectiveness of DN [16, 18].
Physical therapy approaches continue to evolve and in-
clude the combination of DN and electrolysis, known as
percutaneous needle electrolysis (PNE), with promising
results for the treatment of tendon pathologies [20–22].
The PNE technique is a minimally invasive treatment
that consists of the application of a galvanic electrolytic
current that causes a controlled local inflammatory
process in the target tissue. This promotes phagocytosis
and the subsequent regeneration of the affected tissue
[20, 21]. Nowadays, PNE is being used in clinical prac-
tice to manage MTrPs; however, there are no studies
supporting any additional beneficial effects over DN.
Furthermore, there are cost variations between these
techniques, which affect the healthcare system. A
cost-effectiveness comparison will determine which
treatment intervention is the most efficient.
From a biological point of view, it seems reasonable to
hypothesize that subjects can display improvements
thanks to the mechanical effects of the needle and that
patients may benefit more when the electrolysis effect
is added to the mechanical stimulus provided by the
needle. Therefore, the aim of this randomized con-
trolled study is to compare the effectiveness of DN




The study subjects will be adults of both genders who
have been admitted to the Physical Medicine and Re-
habilitation Department in a Kuwait City hospital by a
medical registered doctor from the Ministry of Health.
To be eligible for the study, participants will have to
meet the following inclusion criteria:
– Clinical diagnosis of PHP in accordance with the
Clinical Guidelines linked to the International
Classification of Function, Disability and Health
from the Orthopedic Section of the American
Physical Therapy Association [3, 4, 16, 18]
– Age between 21 and 60 years at admission to the
study, according to the Kuwaiti law
– History of plantar heel pain for over 1 month,
showing no improvements with previous
conservative treatment
– Able to walk 50 m without any support
– The presence of MTrPs on plantar and calf muscles,
based on initial physical examination carried out by
a physiotherapist (MA) with experience and training
in MTrPs
– Accepting treatment from a male physiotherapist
– The ability to understand the study and the informed
consent, as well as having signed the document
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Exclusion criteria for the study will be based on:
– Needle phobia
– Needle allergy or hypersensitivity to metals
– Presence of coagulopathy or use of anticoagulants
according to medical criteria
– Presence of peripheral arterial vascular disease
– Pregnancy
– Dermatological disease affecting the dry needling
area
– The presence of a chronic medical condition which
might preclude participation in the study, such as
malignancy, systemic inflammatory disorders (e.g.,
rheumatoid arthritis, psoriatic arthritis, ankylosing
spondylitis, septic arthritis), neurological diseases,
polyneuropathy, mononeuropathy, and sciatica
– Treatment of plantar heel pain with needling or
acupuncture during the last 4 weeks
– A history of injection therapy in the heel over the
previous 3 months
– Previous history of foot surgery or fracture
Participants will be controlled by using the appropriate
medication dosage as prescribed by the physiatrist (analge-
sics and non-steroidal anti-inflammatory medications) and
will be required to report any changes to the assessor dur-
ing the evaluations if they take any additional medication
or undergo any treatment during the intervention. They
must be willing not to receive or implement any form of
treatment for the plantar heel pain (taping, night splints,
massage therapy, or footwear modifications) while they
participate in the trial. The participants will have the right
to withdraw from the study at any time without having to
provide any explanation.
Regarding sample size, 94 participants with PHP will
be recruited. An initial prospective sample size calcula-
tion estimated that 39 participants per group will pro-
vide 80% power to detect a minimally important
difference of 13 points in the pain domain of the Foot
Health Status Questionnaire (FHSQ) with a standard de-
viation of 20 points [23] and an alpha risk at 0.05, allow-
ing 20% loss to follow-up (16 patients).
Study design
Both the assessment and intervention will take place at
the Physical Medicine and Rehabilitation Hospital in
Kuwait.
This study is a prospective, two parallel groups (par-
ticipant) randomized controlled trial with blinded out-
come assessment at baseline and at 4, 8, 12, 26, and 52
weeks. The study flow chart shown in Fig. 1 conforms to
the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) guidelines for nonphar-
macological studies [24].
Participants who fulfill the inclusion criteria will re-
ceive the standardized oral and written information and,
once they consent to participate in the trial, will be ran-
domized in a block system by blocks of 10 patients. Al-
location to the groups will be achieved using a computer
program (Randomizer, https://www.randomizer.org/)
with random patient file number sequences generated by
a third person not involved in the study, and based on
their file number in Kuwait. This person will be respon-
sible for safekeeping the envelope with the information
of the randomization. The envelopes will remain
closed until the moment of the intervention in order
to maintain the blinding. This professional will also
ask the patients for informed consent. This research
study was approved by the Medical Ethics Committee
of the State of Kuwait Ministry of Health, with refer-
ence number 642/2017.
Interventions
To determine what muscles will be treated, muscles ful-
filling the following two criteria will be selected: (a) mus-
cles that typically refer pain to the heel [17] and (b)
muscles that can be directly palpated or that can be nee-
dled with precision and safety without ultrasound guid-
ance. The clinician will perform a physical examination
to find MTrPs following Travell and Simons’ criteria: (1)
the presence of a taut band and (2) identification of an
exquisite spot tenderness or a nodule [17]. A flat palpa-
tion or pincer palpation technique will be used to pal-
pate the MTrPs, depending on the muscle being
assessed. The muscles to be treated will be the soleus,
gastrocnemius, quadratus plantae, flexor digitorum bre-
vis, and abductor hallucis. If a muscle contains more
than one MTrP, the most sensitive MTrP will be
treated, according to the patient’s perceived pain upon
palpation. If the patient has pain bilaterally, the clin-
ician will treat both sides. The position of the patient
will always be lying; however, it depends on each
muscle (supine, prone, or lateral decubitus position),
and will be the same for the assessment as well as
for the intervention [25].
During the first session, all participants will be taught
a self-stretching protocol [15] which has demonstrated
to be effective for the management of PHP [10, 15, 26]
and will consist of the following exercises: (a) Self-
stretching of the calf muscles: in standing, with the af-
fected foot furthest away from the wall, the patient will
be instructed to lean forward, while keeping the heel on
the floor. To focus the stretching on the soleus muscle,
the affected knee will be bent, whereas to focus on the
gastrocnemius muscle, the affected knee will be kept in
full extension. In this position, patients will be taught to
lean forward until they feel a stretch in the calf and/or
Achilles region. All patients will complete both versions
Al-Boloushi et al. Journal of Orthopaedic Surgery and Research           (2019) 14:31 Page 3 of 8
of the stretch. (b) Plantar fascia-specific self-stretching:
in the sitting position, patients will cross the affected
foot over the contralateral thigh. The patient will place
his/her fingers over the base of the toes, grasp the base
of the toes, and pull the toes back towards the shin, until
a stretch is felt in the plantar fascia [15]. According to
the evidence, we will follow the same dosage for calf and
plantar fascia-specific self-stretching exercises, twice a
day, using intermittent stretching lasting 20 s, followed
by 20-s rest periods for a total of 3 min per stretch [15].
Participants will receive four individual physiotherapy
sessions, once a week. The duration of the sessions may
change depending on the patient; however, these will last
approximately 30min. Participants will be treated by a
physical therapist registered at the Kuwait Ministry of
Health and trained in the protocol. The clinician will have
a minimum of 5 years practical experience in the field of
dry needling and appropriate training.
Invasive interventional groups: dry needling and
percutaneous needle electrolysis
Specific needles for dry needling will be used during in-
vasive treatments (Agu-punt, Spain). Needle length will
be determined by the location of the MTrP and will
Fig. 1 Flow diagram. Randomized controlled trial design
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range from 30 to 50mm in length (or longer if necessary
according to patients’ characteristics). The diameter of
the needle will be 0.25–0.30 mm. If the participant is
sensitive to the needle insertion, the level of manipula-
tion will be reduced. If this measure proves insufficient
for reducing the painful stimulus, manipulation of the
needle will cease altogether and the needle will be left in
situ [25, 27].
To maintain appropriate hygienic conditions during
the invasive treatments, the clinician will wear latex
gloves and thoroughly clean the skin of the area to be
needled with an antiseptic solution (70% Propan-2-ol,
Skin-des). Upon removal of the needle, the area will be
firmly compressed for 10 s. The needle will be discarded
after each single use.
In both groups, the intervention will be terminated
in the case of severe adverse effects, if the participant
does not wish to continue, and if there is an un-
approved use of medication. Any adverse effects will
be duly reported.
Dry needling arm
Once the clinician locates the MTrP, the needle will be
inserted over the same and a rapid needle entry will be
performed. The chosen technique for manipulating the
needle will be the technique described by Hong [28],
which consists of a rapid needle entry and exit (fast in/
fast out), in order to obtain a local twitch response
(LTR), lasting 5 s employing a rhythmic movement at
approximately 1 Hz/sec (five entries). The number of
LTRs will be counted and registered.
Percutaneous needle electrolysis arm
The electrotherapy equipment used (Physio Invasiva,
PRIM Fisioterapia, Spain) produces a continuous gal-
vanic current through the cathode while the patient
holds a hand-held anode [22]. Once the needle reaches
the relevant treatment area, this will be needled in
exactly the same manner as in the DN group, with the
only difference being that the needle will be transmitting
an electrical current with an intensity of 1.5 mA (inten-
sity may be adapted to patient’s characteristics according
to their pain’s tolerance).
Study variables
Baseline data
Baseline data will include gender, age, height, weight,
BMI, details regarding the affected side (right, left, or bi-
lateral), duration of symptoms, medication, and previous
treatments.
A blinded observer will assess all participants at base-
line and at 4, 8, 12, 26, and 52 weeks post-treatment
(Fig. 2).
Primary outcome measure
Participants will complete the FHSQ at baseline and at 4,
8, 12, 26, and 52 weeks post-treatment. The FHSQ con-
sists of 13 questions reflecting four foot health-related do-
mains: pain (4 questions), function (4 questions), footwear
(3 questions), and general foot health (2 questions). Indi-
vidual item scores will then be re-coded, tabulated, and fi-
nally transformed to a scale ranging from 0 to 100 for
each of the four domains [29]. Greater scores reflect better
foot health and quality of life [30]. The FHSQ has been
validated [31] and has been used in similar trials that have
evaluated the effectiveness of different interventions for
plantar heel pain [18, 32, 33].
Secondary outcome measures
Participants will complete the visual analogue scale (VAS) at
baseline and at the 4-, 8-, 12-, 26-, and 52-week assessments
and additionally before each treatment session. The level of
pain that patients have experienced during the previous 48 h
prior to starting the treatment session will be recorded. Par-
ticipants will be asked about the mean and the highest level
of pain they have experienced. The exact wording of the
questions will be: (1) what is the level of pain, on average,
that you have felt during the last 48 h? and (2) what is the
maximum level of pain you have felt during the last 48 h?
Additionally, after treatment, they will be asked to score
their current pain immediately upon standing up and walk-
ing a few steps. Participants will be explained that a score of
0 indicates the absence of pain, whereas a score of 10 repre-
sents the maximum tolerable pain. The VAS is widely used
and is valid and reliable [34–36]. They will also indicate the
areas of perceived pain on an electronic body chart (Navi-
gate pain, version 0.1.9.9, Aalborg, Denmark) [37].
Quality of life (QoL) will be assessed with the
EuroQoL-5 dimensions (EQ-5D), which will be filled out
by the patients at baseline and at the 4-, 8-, 12-, 26-, and
52-week assessments. The EQ-5D self-report question-
naire is a descriptive system with five questions, each
representing one dimension of health-related quality of
life (HRQoL), i.e., mobility, self-care, daily activities, pain/
discomfort, and depression/anxiety. Each dimension can
be rated on three levels: no problems, some problems, and
major problems, and together, the results serve to classify
people into 1 of 243 possible health states [38].
Cost analysis
Costs will be collected from the healthcare viewpoint. Dir-
ect healthcare costs are the costs of manual therapy,
physiotherapy or general practitioner care, additional visits
to other healthcare providers, drugs, and hospitalization.
Cost-effectiveness and cost-utility analyses will be carried
out with quality-adjusted life-year, estimated from EQ-5D
scores.
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Statistical analysis
The statistical analysis will be performed via an
intention-to-treat analysis. Variables will be described in
number (percentage) and average (standard deviation) or
median (interquartile range), according to their distribu-
tion. Quantitative variables will be analyzed with the
Shapiro Wilk test in order to confirm their distribution
and to determine the correct statistical tests according
to these results.
The outcomes will be analyzed using mixed linear and
logistic regression models considering participants as a
random effect and treatment group as fixed factors.
Baseline characteristics will be introduced in the model
as covariance factors. The numbers needed to treat index
will also be calculated. The primary aim of the analysis
will be to calculate the difference obtained in the FHSQ
score after the intervention (final measurement − initial
measurement). Finally, the magnitude of the effect of the
result will be calculated and, therefore, its clinical import-
ance, by using the following formula: r = √[F(1,dfR)]/
[F(1,dfR)+dfR].
The significance level for statistical tests will be set at
p ≤ 0.05.
Ethics and dissemination
The study design, procedures, and informed consent
procedure were approved by the Ministry of Health in
the state of Kuwait on 19 September 2017, and the study
will be conducted in compliance with the Helsinki
Declaration of Human Rights. The registration number
provided by ClinicalTrials.gov is NCT03236779 (regis-
tered 2 August 2017). Participants will be requested to
provide informed written consent before randomization.
The software used to assemble the papers included in
this review will be EndNote X7 v17.0.1. The participant
data obtained in this ongoing research will not to be
used for other purposes. All the personal information
collected such as the informed consent form and the
physical examination findings will be stored by category
in a specific filing cabinet before, during, and after the
trial, in order to protect confidentiality. After completing
the data analysis, and regardless of the findings, we plan
to disseminate all the trial results via conferences and
publications.
Discussion
Plantar heel pain is a common cause of foot pain and
discomfort affecting the health and quality of life of pa-
tients, with a high tendency for relapse and chronicity
[8]. Previous studies have demonstrated the positive ef-
fect of conservative treatment in reducing painful condi-
tions associated to PHP [15, 19], while other RCTs show
that DN probably has a higher potential benefit over
more conservative approaches [16]. Nevertheless, ac-
cording to systematic reviews, new high-quality RCTs
are needed on which to base the evidence regarding the
effectiveness of DN for symptoms management in PHP
[39]. Despite the fact that the plantar fascia can be a
Fig. 2 Schedule for enrolment and intervention
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source of pain in itself [40] and that other studies per-
forming invasive treatments have considered needling
upon the insertion of the plantar fascia [41], our hypoth-
esis is restricted to evaluating the contribution of MTrPs
towards PHP.
As an innovative treatment modality, PNE is being in-
creasingly used in order to promote the regeneration of
injured tendons [20–22, 42] and is being gradually recog-
nized as a cornerstone for invasive approaches in physio-
therapy. However, despite the fact that its use is increasing
based on an apparently additional effect to only DN, there
is no scientific evidence to support the use of this tech-
nique in clinical practice. Due to this fact, our aim is to re-
search whether PNE can offer an additional effect to DN
for PHP management. To our knowledge, this will be the
first study to compare two invasive treatments for MTrPs
associated with PHP. Not only this study will contribute
to research regarding the possible additional effects of
PNE, but also by analyzing differences in pain perception
after therapy, it will address a common patient complaint.
Furthermore, cost-effectiveness data will be extracted
based on the EQ-5D, thus providing a valuable economic
variable to studies involving physiotherapy techniques.
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